Average cost

indie Semiconductor Reports First Quarter 2024 Results

Retrieved on: 
torsdag, maj 9, 2024
Vehicle Technology, Semiconductor, Automotive, EV, Electric Vehicles, Technology, Software, Hardware, Use, Internet, GAAP, Average cost, Radar, Conference, Telephone, Growth, Finance

indie Semiconductor, Inc. (Nasdaq: INDI), an Autotech solutions innovator, today announced first quarter results for the period ended March 31, 2024.

Key Points: 
  • indie Semiconductor, Inc. (Nasdaq: INDI), an Autotech solutions innovator, today announced first quarter results for the period ended March 31, 2024.
  • On a GAAP basis, first quarter 2024 operating loss was $49.6 million compared to $37.0 million a year ago.
  • Non-GAAP operating loss for the first quarter of 2024 was $17.2 million, versus $16.8 million during the same period last year.
  • First quarter 2024 GAAP loss per share was $0.19, while Non-GAAP loss per share was $0.10.

Cambium Networks Reports First Quarter 2024 Financial Results

Retrieved on: 
torsdag, maj 9, 2024
Supplement, Average cost, FCC, Conference, Cambium Networks, Archive, Enterprise, Telephone, Federal Communications Commission, Calendar, GAAP, Growth, Video game

GAAP gross margin for the first quarter 2024 was 20.5%, compared to 51.2% for the first quarter 2023, and (27.4%) for the fourth quarter 2023.

Key Points: 
  • GAAP gross margin for the first quarter 2024 was 20.5%, compared to 51.2% for the first quarter 2023, and (27.4%) for the fourth quarter 2023.
  • GAAP operating loss for the first quarter 2024 was $21.0 million, compared to operating income of $5.6 million for the first quarter 2023, and operating loss of $41.6 million for the fourth quarter 2023.
  • Non-GAAP operating loss for the first quarter 2024 was $16.7 million, compared to non-GAAP operating income of $9.4 million for the first quarter 2023, and a non-GAAP operating loss of $36.4 million for the fourth quarter 2023.
  • Cambium Networks' financial outlook does not include the potential impact of any possible future financial transactions, acquisitions, pending legal matters, or other transactions.

EQS-News: ADTRAN Holdings, Inc. reports first quarter 2024 financial results

Retrieved on: 
fredag, maj 10, 2024
Table, Information, Central Time, Average cost, Risk, ADTRAN, Annual report, Security (finance), Transport, Weakness, ADTN, Acquisition, Loss, Central European, Judgement, Bank statement, Name, GAAP, Earnings

— May 06, 2024 — ADTRAN Holdings, Inc. (NASDAQ: ADTN and FSE: QH9) (“ADTRAN Holdings” or the “Company”) today announced its unaudited financial results for the first quarter of 2024.

Key Points: 
  • — May 06, 2024 — ADTRAN Holdings, Inc. (NASDAQ: ADTN and FSE: QH9) (“ADTRAN Holdings” or the “Company”) today announced its unaudited financial results for the first quarter of 2024.
  • GAAP net loss attributable to the Company for the first quarter of 2024, including the above mentioned impairment charge, was $324.6 million.
  • Non-GAAP net loss attributable to the Company for the first quarter of 2024 was $1.7 million.
  • ADTRAN Holdings’ Chairman and Chief Executive Officer Tom Stanton stated, "First quarter revenue and profitability came in as expected, with the weakness still impacting our results.

EQS-News: Adtran Networks SE announces results for Q1 2024

Retrieved on: 
fredag, maj 10, 2024
Behavior, EUR, Operating cost, Average cost, Beauty salon

2 Q1 2024 including EUR 3.7 million, Q4 2023 including EUR 7.8 million, Q1 2023 including EUR 1.6 million extraordinary expenses

Key Points: 
  • 2 Q1 2024 including EUR 3.7 million, Q4 2023 including EUR 7.8 million, Q1 2023 including EUR 1.6 million extraordinary expenses
    3 Q1 2024 including EUR 53.2 million, Q4 2023 including EUR 52.8 million, Q1 2023 including EUR 0 million financial liabilities to Adtran Holdings, Inc.. Q1 2024 furthermore including EUR 4.8 million and Q4 2023 including EUR 13.3 million financial liabilities due to the consideration of a new receivables purchasing program
    Revenue in Q1 2024 was down 7.5% to EUR 109.6 million from EUR 118.5 million in Q4 2023 and was also down 38.9% compared to EUR 179.4 million in Q1 2023.
  • Pro forma gross profit in Q1 2024 was down 16.3% to EUR 39.7 million (36.3% of revenues) from EUR 47.5 million (40.1% of revenues) in Q4 2023 and decreased by 31.9% from EUR 58.4 million (32.5% of revenues) in Q1 2023.
  • Operating loss increased from EUR 1.1 million in Q4 2023 to EUR 8.8 million in Q1 2024 and from an operating income of EUR 6.2 million in Q1 2023.
  • Net loss was EUR 1.2 million in Q1 2024, compared to a net loss of EUR 22.7 million in Q4 2023 and to a net income of EUR 3.6 million in Q1 2023.

VALHI REPORTS FIRST QUARTER 2024 RESULTS

Retrieved on: 
torsdag, maj 9, 2024
Corporation, Chemical substance, Cyberattack, Titanium dioxide, Average cost, Safety, Health, Zinc, Biophysical environment, Gross domestic product, Insurance, Environment, Steel, VHI, Aluminium, Property, Government, Risk management

The Chemicals Segment’s net sales of $478.8 million in the first quarter of 2024 were $52.5 million, or 12%, higher than in the first quarter of 2023.

Key Points: 
  • The Chemicals Segment’s net sales of $478.8 million in the first quarter of 2024 were $52.5 million, or 12%, higher than in the first quarter of 2023.
  • The Chemicals Segment’s TiO2 sales volumes were 28% higher in the first quarter of 2024 as compared to the first quarter of 2023.
  • Average TiO2 selling prices were 11% lower in the first quarter of 2024 as compared to the first quarter of 2023.
  • TiO2 production volumes were 15% higher in the first quarter of 2024 compared to the first quarter of 2023.

AvePoint Announces First Quarter 2024 Financial Results

Retrieved on: 
torsdag, maj 9, 2024
Public sector, Total, Investment, ARR, Average cost, Certification, Webcast, Software as a service, Entrepreneurship, FedRAMP, AvePoint, HITRUST, First officer (aviation), Microsoft, SOC, Data management, FX, GAAP, Growth, Video game

JERSEY CITY, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- AvePoint (NASDAQ: AVPT), a global leader in robust data management and data governance, today announced financial results for the first quarter ended March 31, 2024. 

Key Points: 
  • First quarter SaaS revenue of $51.3 million, representing 44% year-over-year growth
    First quarter Total revenue of $74.5 million, representing 25% year-over-year growth
    Total ARR of $274.5 million, representing 23% year-over-year growth
    JERSEY CITY, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- AvePoint (NASDAQ: AVPT), a global leader in robust data management and data governance, today announced financial results for the first quarter ended March 31, 2024.
  • Gross Profit: GAAP gross profit was $54.1 million, compared to $41.7 million for the first quarter of 2023.
  • For the second quarter of 2024, the Company expects:
    Total revenues of $73.8 million to $75.8 million, or year-over-year growth of 15% at the midpoint.
  • AvePoint will host a conference call today, May 9, 2024, to review its first quarter 2024 financial results and to discuss its financial outlook.

BigCommerce Announces First Quarter 2024 Financial Results

Retrieved on: 
torsdag, maj 9, 2024
Titan, Next Big Thing, BigCommerce, BIGC, NetSuite, Total, Catalysis, Stencil, Language, ARR, Average cost, Commerce, Collection, Webcast, Software as a service, Bollman Hat Company, Karava, Dickies, Joseph Mercola, Pet, ARPA, Marketing, Whirlpool Corporation, GAAP, Accenture, Global health

AUSTIN, Texas, May 09, 2024 (GLOBE NEWSWIRE) -- BigCommerce Holdings, Inc. (“BigCommerce”) (Nasdaq: BIGC), an open SaaS, composable ecommerce platform for fast-growing and established B2C and B2B brands and retailers, today announced financial results for its first quarter ended March 31, 2024.

Key Points: 
  • AUSTIN, Texas, May 09, 2024 (GLOBE NEWSWIRE) -- BigCommerce Holdings, Inc. (“BigCommerce”) (Nasdaq: BIGC), an open SaaS, composable ecommerce platform for fast-growing and established B2C and B2B brands and retailers, today announced financial results for its first quarter ended March 31, 2024.
  • “Our first quarter results reflect a good start to the year as our total revenue exceeded $80 million, up 12% year-over-year.
  • Q2 and 2024 Financial Outlook:
    For the second quarter of 2024, we currently expect:
    Total revenue between $79.8 million to $81.8 million, implying a year-over-year growth rate of 6% to 8%.
  • ET) on Thursday, May 9, 2024, to discuss its financial results and business highlights.

Cronos Group Reports 2024 First Quarter Results

Retrieved on: 
torsdag, maj 9, 2024
Cream, Mazor Robotics, Genetics, Certified Public Accountant, Wedding cake, Investment, Fully Charged, Average cost, Capital, EY, Pharma, Depreciation, Cannabinol, Flower, Robotics, Traction, GMO, Partnership, Research, Capital expenditure, Medtronic, Tax, Senior, Patient, Vii, Hamas, CBC, Motus, CBN, Lord, CBG, Growth, Drug

TORONTO, May 09, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), today announces its 2024 first quarter business results.

Key Points: 
  • Cronos Growing Company Inc. ("Cronos GrowCo") reported to the Company preliminary unaudited net revenue to licensed producers, excluding sales to the Company, of approximately $5.1 million in the first quarter of 2024.
  • Cronos previously provided Cronos GrowCo with a senior secured credit facility, which currently has approximately $67.1 million outstanding following a principal repayment of $1.2 million by Cronos GrowCo in Q1 2024.
  • In addition to principal repayment, Cronos also received $1.4 million in interest payments from Cronos GrowCo, totaling approximately $2.7 million in cash payments to Cronos in Q1 2024.
  • Before becoming Head of Cronos Israel, he was the Vice President of Finance at Cronos Israel managing the Cronos Israel finance department.

Myriad Genetics Reports Strong First Quarter 2024 Financial Results; Achieves 12% Revenue Growth Year-Over-Year; Significantly Improved Year-Over-Year Net Loss and Generated Positive Adjusted EBITDA

Retrieved on: 
tisdag, maj 7, 2024
Sale, American College, Average cost, MRD, Test management, Myriad Genetics, Intermountain, Research, Forecasting, CLIA, Medical genetics, Genetics, DNA, DSM-IV codes, AAPP, Patient, Operating cost, ASPS, Women's health, Genomics, Cancer, GAAP, Pharmaceutical industry

SALT LAKE CITY, May 07, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced financial results for its first quarter ended March 31, 2024 and reiterated its previously issued outlook on business performance for the full-year 2024.

Key Points: 
  • Adjusted gross margin in the first quarter of 2024 was 68.5%, an increase of 80 basis points year-over-year.
  • Operating loss in the first quarter of 2024 was $27.9 million, improving $24.3 million year-over-year; adjusted operating loss in the first quarter of 2024 was $0.6 million, improving $21.3 million year-over-year.
  • The Oncology business delivered revenue of $79.4 million in the first quarter of 2024.
  • Prolaris first quarter 2024 revenue grew 9% year-over-year, benefiting, in part, from improved payer coverage.

SOPHiA GENETICS Reports First Quarter 2024 Results

Retrieved on: 
tisdag, maj 7, 2024
Liquid biopsy, Table, Mayo Clinic, Cancer, NHS, Health equity, COVID, Average cost, Book of Wisdom, Breast cancer, FY, GENETICS, Traction, Sophia Genetics, Research, Forecasting, Growth, SOPHIA, NGS, Public expenditure, Algorithm, Patient, MSK, Eastern Time Zone, Acquisition, Medicine, Pension, COVID-19, AstraZeneca, Constant, Central European Time, Pharmaceutical industry

BOSTON and ROLLE, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, today reported financial results for the first quarter ended March 31, 2024.

Key Points: 
  • BOSTON and ROLLE, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, today reported financial results for the first quarter ended March 31, 2024.
  • SOPHiA GENETICS will host a conference call and live webcast to discuss the first quarter 2024 results on Tuesday, May 7, 2024, at 8:00 a.m. (08:00) Eastern Time / 2:00 p.m. (14:00) Central European Time.
  • The call will be webcast live on the SOPHiA GENETICS Investor Relations website, ir.sophiagenetics.com.
  • Additionally, an audio replay of the conference call will be available on the SOPHiA GENETICS website after its completion.